NervGen Pharma Corp. (NGEN)

1.73 -0.02 (-1.14%) USD  |  NASDAQ  |  Oct 09, 16:00
1.73 0.00 (0.00%) After-Hours: 20:00
More

NervGen Pharma Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for NGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2025. Start Trial.
Date Value
September 30, 2026 --
August 13, 2026 --
July 14, 2026 --
July 13, 2026 --
June 11, 2026 --
May 22, 2026 --
May 19, 2026 --
May 18, 2026 --
April 28, 2026 --
April 27, 2026 --
April 15, 2026 --
Date Value
April 08, 2026 --
April 07, 2026 --
March 31, 2026 --
January 08, 2026 --
November 24, 2025 --
August 26, 2025 --
July 17, 2025 --
June 02, 2025 --
May 15, 2025 --
April 17, 2025 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
InMed Pharmaceuticals, Inc. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Clearmind Medicine, Inc. --
Lexaria Bioscience Corp. Upgrade
Target Group, Inc. (Canada) --

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade